MTOR and breast carcinoma: When predicting the sensitivity of breast cancer cell lines to Torin2, a polyselective mammalian target of rapamycin (mTOR) inhibitor,34 we found that 526 out of 673 rankable pairs were ranked correctly by a random forest model (AUC estimate = 0.78).